Filter by tags: Radiopharmaceutical Rosatom Clear all tag filters
11 news articles found
Russia's Rosatom has signed agreements relating to developing nuclear medicine centres in Nicaragua and Kazakhstan, and also a memorandum of understanding with Burkina Faso which includes potential nuclear energy projects.
- Source: World Nuclear News
- Date: Wednesday, 27 March 2024
- Original article: world-nuclear-news.org/Articles/Agreements-Burkina-Faso,-Nicaragua-and-Kazakhstan
Kyrgyzstan's Ministry of Health and Rosatom are working together on a new nuclear medicine diagnostic centre at the National Centre for Oncology and Haematology in Bishkek, with the latest stage being the delivery of a technetium-99m GT-4K generator.
- Source: World Nuclear News
- Date: Friday, 04 August 2023
- Original article: world-nuclear-news.org/Articles/Nuclear-medicine-project-in-Kyrgyzstan-making-prog
President Luis Arce Catacora has delivered the first fluorodeoxyglucose radiopharmaceuticals produced in Bolivia's new Cyclotron Preclinical Radiopharmacy Complex (CRPC) to patients of the Nuclear Medicine and Radiotherapy Centres of El Alto and Santa Cruz.
- Source: World Nuclear News
- Date: Saturday, 11 March 2023
- Original article: world-nuclear-news.org/Articles/Bolivia-s-first-radiopharmaceuticals-supplied
Rosatom has begun construction of a new plant for the production of medical isotope products at the Karpov Scientific Research Institute of Physics & Chemistry in Obninsk, Kaluga region. The plant will produce a wide range of radiopharmaceuticals including those based on iodine-131, samarium-153, and molybdenum-99 isotopes. It will also develop promising active radiopharmaceuticals based on lutetium-177, actinium-225, radium-223 and other isotopes. Once completed, in 2025, it will be the largest such facility in Europe, Rosatom says. It will operate in accordance with international GMP (good manufacturing practice) standards.
- Source: NEI Magazine
- Date: Friday, 27 January 2023
- Original article: neimagazine.com/news/newsrosatom-begins-construction-of-radiopharmaceuticals-plant-10546229
The aim is to have production lines operating at the plant in Obninsk by 2025, supplying products for the diagnosis and treatment of patients, including a wide range of cancers. Rosatom says it will ensure Russia's sovereignty in the production of radiopharmaceuticals.
- Source: World Nuclear News
- Date: Wednesday, 25 January 2023
- Original article: world-nuclear-news.org/Articles/Construction-starts-for-Russian-medical-isotopes-p
Rosatom has launched a trial operation of the first industrial facilities at the Centre for Nuclear Research and Technology (CNRT) under construction in El Alto, Bolivia, the world’s highest altitude nuclear centre situated 4,000 metres above sea level. A ceremony was held to marking trial operation the first industrial facilities of the CNRT - the preclinical cyclotron-radiopharmacological complex (PCRC) and the multipurpose irradiation centre (MCC). The event was attended by CEO of the Bolivian Atomic Energy Agency Ortesia Jimenez and President of JSC Rusatom Overseas Evgeny Pakermanov.
- Source: NEI Magazine
- Date: Saturday, 13 August 2022
- Original article: neimagazine.com/news/newstrial-operation-begins-at-bolivias-nuclear-research-and-technology-centre-9924570
The world’s highest altitude Centre for Nuclear Technology Research and Development (CNTRD) under construction by Rosatom in El Alto, Bolivia, has completed testing of its radiopharmaceuticals production line.
- Source: NEI Magazine
- Date: Wednesday, 05 January 2022
- Original article: neimagazine.com/news/newsradiopharmaceutical-production-equipment-tested-in-bolivia-9360523
Bolivia / Russia Tests Production Facilities For Radiopharmaceuticals At New Nuclear Research Centre
According to Rosatom, radiopharmaceuticals produced at the site will be used in more than 5,000 medical procedures a year in Bolivia. Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. They can be used as diagnostic and therapeutic agents.
Rosatom said commissioning work is continuing at the facility, which will include a water-cooled research reactor with nominal power of up to 200 kW, an experimental gamma-installation, a cyclotron and radiopharmacology complex, engineering facilities and various laboratories.
- Source: Nucnet
- Date: Thursday, 30 December 2021
- Original article: nucnet.org/news/russia-tests-production-facilities-for-radiopharmaceuticals-at-new-nuclear-research-centre-12-3-2021
Isotop JSC (part of Rusatom Healthcare, Rosatom’s radiation technologies integrator) on 9 June signed a five-year contract with Brazil’s Nuclear and Energy Research Institute (IPEN, part of the National Nuclear Energy Commission, CNEN) to supply medical isotopes lutetium-177 and actinium-225.
- Source: NEI Magazine
- Date: Friday, 11 June 2021
- Original article: neimagazine.com/news/newsrosatom-to-supply-brazil-with-key-medical-isotopes-8810883
Rusatom Healthcare, part of state nuclear corporation Rosatom, will build Russia’s first radiopharmaceutical plant to meet global GMP good manufacturing practice standards. The new production facility will be in Obninsk at the site of LYa Karpov Scientific Research Institute of Physics & Chemistry (NIFKhl) and will produce drugs for targeted cancer therapy. The design of pharmaceutical production will be carried out by the Central Design and Technological Institute. Pre-design work is planned to be completed this year, for commissioning in 2024 production in early 2025.
- Source: NEI Magazine
- Date: Friday, 07 August 2020
- Original article: neimagazine.com/news/newsrussia-to-open-radiopharmaceutical-plant-in-obninsk-8064702